| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | 0.027 | 0.5 |
| mRNA | KHS101 | CTRPv2 | pan-cancer | AAC | -0.027 | 0.5 |
| mRNA | CD-1530 | CTRPv2 | pan-cancer | AAC | -0.027 | 0.5 |
| mRNA | CAY10594 | CTRPv2 | pan-cancer | AAC | -0.027 | 0.5 |
| mRNA | YM201636 | GDSC1000 | pan-cancer | AAC | 0.022 | 0.5 |
| mRNA | ML258 | CTRPv2 | pan-cancer | AAC | -0.027 | 0.5 |
| mRNA | BRD-K88742110 | CTRPv2 | pan-cancer | AAC | 0.026 | 0.5 |
| mRNA | Axitinib | GDSC1000 | pan-cancer | AAC | 0.025 | 0.5 |
| mRNA | GSK429286A | GDSC1000 | pan-cancer | AAC | 0.023 | 0.5 |
| mRNA | NG-25 | GDSC1000 | pan-cancer | AAC | -0.021 | 0.5 |